Tumor board simulation improves interdisciplinary decision-making in medical students.
Decision-making
Medical education
Oncology
Tumor board simulation
Journal
Journal of cancer research and clinical oncology
ISSN: 1432-1335
Titre abrégé: J Cancer Res Clin Oncol
Pays: Germany
ID NLM: 7902060
Informations de publication
Date de publication:
30 Aug 2024
30 Aug 2024
Historique:
received:
15
06
2024
accepted:
23
07
2024
medline:
31
8
2024
pubmed:
31
8
2024
entrez:
30
8
2024
Statut:
epublish
Résumé
Training of interdisciplinary clinical reasoning and decision-making skills, essential in daily clinical practice in oncological specialties, are still underrepresented in medical education. Therefore, at LMU University Hospital Munich, we implemented a didactically modified tumor board simulation with experts from five different disciplines (medical oncology, pathology, radiation oncology, radiology, and surgery) presenting patient cases into a one-week course on the basic principles of oncology. In this survey, we examined the self-assessed impact of our course on the interdisciplinary decision-making skills of medical students. Between November-December 2023 and January-February 2024, we surveyed two cohorts of medical students in the third year of medical school in our one-week course before and after participating in the tumor board simulation. The objective was to evaluate the self-assessed knowledge in interdisciplinary clinical decision-making, in integrating ethical considerations into clinical reasoning, and in comprehension of various professional viewpoints in interdisciplinary decision-making. Knowledge was assessed using a five-step Likert scale from 1 (no knowledge) to 5 (complete knowledge). The survey was answered by 76 students before and 55 after the simulation, equaling 60-70% of all 100 course participants. Mean knowledge level regarding principles of interdisciplinary clinical decision-making improved significantly in all of the following exemplary aspects: purpose and procedure of tumor boards in clinical practice (from 2.4 ± 1.1 to 4.0 ± 1.0, Spearman's ρ = 0.6, p < 0.001), principles of dealing with ethical challenges in oncology (from 2.4 ± 1.1 to 3.4 ± 1.0, ρ = 0.4, p < 0.001), and principles of shared decision-making in oncology (2.7 ± 1.1 to 3.7 ± 1.0, ρ = 0.4, p < 0.001). Students reported that their skills in clinical decision-making and ability to discuss oncological patient cases from different professional viewpoints improved due to the teaching course. By employing our interdisciplinary one-week course and a didactically modified tumor board simulation featuring experts from various oncological disciplines, medical students' comprehension of interdisciplinary clinical decision-making in oncology improved significantly.
Identifiants
pubmed: 39212783
doi: 10.1007/s00432-024-05908-x
pii: 10.1007/s00432-024-05908-x
pmc: PMC11364642
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
407Informations de copyright
© 2024. The Author(s).
Références
J Am Coll Radiol. 2013 Feb;10(2):135-41
pubmed: 23374691
Nat Med. 2022 Apr;28(4):658-665
pubmed: 35440717
Patient Educ Couns. 2003 May;50(1):43-9
pubmed: 12767584
JAMA Oncol. 2022 Mar 01;8(3):420-444
pubmed: 34967848
Med Teach. 2017 May;39(5):505-511
pubmed: 28440719
BMC Med Ethics. 2022 Mar 19;23(1):29
pubmed: 35305627
Eur J Cancer. 2007 Apr;43(6):1002-10
pubmed: 17329094
JCO Oncol Pract. 2022 Jun;18(6):e907-e914
pubmed: 35157507
Ann Oncol. 2006 Mar;17(3):457-60
pubmed: 16322114
J Cancer Res Clin Oncol. 2023 Nov;149(17):16087-16096
pubmed: 37698680
J Am Coll Radiol. 2016 Oct;13(10):1239-1241
pubmed: 27474420
Anat Sci Educ. 2024 Jan-Feb;17(1):11-23
pubmed: 37850629
Front Surg. 2021 Aug 12;8:690680
pubmed: 34458314
J Multidiscip Healthc. 2018 Jan 19;11:49-61
pubmed: 29403284
Int J Gynecol Cancer. 2008 Mar-Apr;18(2):215-22
pubmed: 17511801
Health Policy. 2015 Apr;119(4):464-74
pubmed: 25271171
Eur J Cancer. 2018 Nov;103:356-387
pubmed: 30100160
Eur J Hum Genet. 2024 Apr;32(4):381-391
pubmed: 38378794
Acad Med. 2016 Sep;91(9):1217-22
pubmed: 26959224
J Cancer Res Clin Oncol. 2023 May;149(5):1905-1915
pubmed: 35796778
J Cancer Educ. 2024 Aug;39(4):374-382
pubmed: 38448671
Med Educ. 2001 Sep;35(9):867-75
pubmed: 11555225
Acad Med. 2013 Dec;88(12):1798-801
pubmed: 24128642
Strahlenther Onkol. 2022 Jan;198(1):1-11
pubmed: 34786605
J Cancer Educ. 2018 Jun;33(3):500-504
pubmed: 27581433
J Cancer Educ. 2023 Oct;38(5):1501-1508
pubmed: 37058222
ESMO Open. 2016 Sep 29;1(5):e000097
pubmed: 27843641
Ann Oncol. 2006 Aug;17(8):1337-8
pubmed: 16524967
GMS Z Med Ausbild. 2015;32(3):Doc35
pubmed: 26677513
Acad Med. 2015 Jun;90(6):738-43
pubmed: 25539516
BMC Health Serv Res. 2020 Jan 31;20(1):73
pubmed: 32005232
Med Teach. 2021 Feb;43(2):152-159
pubmed: 33205693
Clin Teach. 2013 Oct;10(5):308-12
pubmed: 24015736
Int J Med Inform. 2018 Jan;109:55-69
pubmed: 29195707
J Cancer Res Clin Oncol. 2023 Sep;149(12):10075-10084
pubmed: 37261525
PLoS One. 2015 Oct 06;10(10):e0139921
pubmed: 26441328
JCO Precis Oncol. 2018 Nov;2:1-14
pubmed: 35135153
J Cancer Res Clin Oncol. 2023 Dec;149(19):17071-17079
pubmed: 37750957
Cancer Treat Rev. 2016 Jan;42:56-72
pubmed: 26643552